research Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents 67 citations , October 2005 in “Annals of Oncology” Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.
research Onychomatricoma with classic features: Case report and review of the literature February 2013 in “Journal of The American Academy of Dermatology” Hair loss is a common side effect of hormone treatments for cancer.